Europe’s medicines regulator said on Friday its safety committee has advised that people who have previously had capillary leak syndrome must not be vaccinated with AstraZeneca and Oxford University’s COVID-19 vaccine, Vaxzevria.
This is a developing story
Photo: (FILE) A vial of the Oxford-AstraZeneca COVID-19 vaccine. EPA-EFE/TOMS KALNINS
